 Henry Galan
Concepts (522)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 51 | 2025 | 587 | 6.540 |
Why?
| | Ultrasonography, Prenatal | 38 | 2025 | 294 | 4.200 |
Why?
| | Placenta | 29 | 2022 | 780 | 2.590 |
Why?
| | Pregnancy | 111 | 2026 | 7191 | 2.510 |
Why?
| | Ultrasonography, Doppler | 19 | 2023 | 126 | 2.480 |
Why?
| | Umbilical Arteries | 12 | 2023 | 52 | 2.260 |
Why?
| | Fetofetal Transfusion | 5 | 2025 | 26 | 1.850 |
Why?
| | Gestational Age | 37 | 2024 | 975 | 1.690 |
Why?
| | Gynecology | 4 | 2022 | 178 | 1.450 |
Why?
| | Uterine Artery | 6 | 2020 | 75 | 1.420 |
Why?
| | Fetus | 24 | 2023 | 803 | 1.380 |
Why?
| | Sheep | 27 | 2017 | 880 | 1.330 |
Why?
| | Laser Coagulation | 2 | 2025 | 77 | 1.300 |
Why?
| | Pregnancy Outcome | 11 | 2024 | 476 | 1.240 |
Why?
| | Meningomyelocele | 5 | 2022 | 61 | 1.210 |
Why?
| | Fetal Diseases | 8 | 2026 | 191 | 1.180 |
Why?
| | Fetal Weight | 7 | 2022 | 54 | 1.130 |
Why?
| | Pregnancy, Twin | 4 | 2022 | 19 | 1.110 |
Why?
| | Fetoscopy | 4 | 2025 | 33 | 1.110 |
Why?
| | Obstetrics | 6 | 2022 | 175 | 1.010 |
Why?
| | Infant, Newborn | 38 | 2026 | 6434 | 0.980 |
Why?
| | Fetal Development | 3 | 2021 | 299 | 0.890 |
Why?
| | Infant, Small for Gestational Age | 7 | 2022 | 109 | 0.880 |
Why?
| | Female | 117 | 2026 | 78376 | 0.880 |
Why?
| | Inositol | 5 | 2014 | 25 | 0.800 |
Why?
| | Hernias, Diaphragmatic, Congenital | 5 | 2025 | 219 | 0.800 |
Why?
| | Delivery, Obstetric | 5 | 2021 | 160 | 0.760 |
Why?
| | Bradycardia | 2 | 2026 | 59 | 0.730 |
Why?
| | Atrioventricular Block | 2 | 2026 | 45 | 0.730 |
Why?
| | Sorbitol | 4 | 2014 | 13 | 0.720 |
Why?
| | Nitric Oxide Synthase Type III | 6 | 2011 | 204 | 0.710 |
Why?
| | Comorbidity | 2 | 2024 | 1660 | 0.700 |
Why?
| | Hydrocephalus | 4 | 2024 | 111 | 0.670 |
Why?
| | Umbilical Veins | 6 | 2009 | 59 | 0.660 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 113 | 0.650 |
Why?
| | Cerclage, Cervical | 2 | 2022 | 9 | 0.640 |
Why?
| | Pregnancy Complications | 7 | 2024 | 592 | 0.620 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 2 | 2010 | 9 | 0.610 |
Why?
| | Uterine Cervical Incompetence | 1 | 2019 | 3 | 0.600 |
Why?
| | Altitude | 4 | 2013 | 473 | 0.580 |
Why?
| | Pregnancy, Animal | 4 | 2012 | 52 | 0.570 |
Why?
| | Birth Weight | 9 | 2021 | 522 | 0.550 |
Why?
| | Pre-Eclampsia | 4 | 2015 | 205 | 0.550 |
Why?
| | Placental Insufficiency | 7 | 2017 | 125 | 0.540 |
Why?
| | Humans | 97 | 2026 | 144957 | 0.540 |
Why?
| | Amniotic Fluid | 8 | 2024 | 79 | 0.530 |
Why?
| | Regional Blood Flow | 8 | 2011 | 514 | 0.490 |
Why?
| | Prenatal Diagnosis | 5 | 2024 | 195 | 0.490 |
Why?
| | Blood Flow Velocity | 7 | 2022 | 413 | 0.490 |
Why?
| | Internship and Residency | 3 | 2022 | 1257 | 0.480 |
Why?
| | Maternal-Fetal Exchange | 8 | 2021 | 169 | 0.470 |
Why?
| | Body Composition | 5 | 2022 | 706 | 0.460 |
Why?
| | Uterus | 3 | 2011 | 226 | 0.420 |
Why?
| | Adipose Tissue | 3 | 2016 | 653 | 0.420 |
Why?
| | Nitric Oxide | 7 | 2011 | 897 | 0.410 |
Why?
| | Amino Acids | 4 | 2021 | 522 | 0.400 |
Why?
| | Premature Birth | 5 | 2024 | 380 | 0.400 |
Why?
| | Nitric Oxide Synthase | 3 | 2006 | 235 | 0.400 |
Why?
| | Fetal Therapies | 5 | 2024 | 47 | 0.400 |
Why?
| | Disease Models, Animal | 15 | 2021 | 4569 | 0.400 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2014 | 173 | 0.390 |
Why?
| | Puerperal Disorders | 2 | 2008 | 37 | 0.380 |
Why?
| | Laser-Doppler Flowmetry | 3 | 2005 | 31 | 0.370 |
Why?
| | Pulsatile Flow | 7 | 2011 | 55 | 0.370 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 601 | 0.360 |
Why?
| | NFATC Transcription Factors | 1 | 2012 | 93 | 0.350 |
Why?
| | Apoptosis | 5 | 2017 | 2430 | 0.340 |
Why?
| | Blood Pressure | 4 | 2017 | 1769 | 0.340 |
Why?
| | Iron-Dextran Complex | 2 | 2003 | 7 | 0.340 |
Why?
| | Retrospective Studies | 19 | 2025 | 17101 | 0.330 |
Why?
| | Organ Size | 11 | 2015 | 463 | 0.330 |
Why?
| | Biometry | 2 | 2008 | 68 | 0.320 |
Why?
| | Amniocentesis | 4 | 2019 | 20 | 0.310 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2009 | 37 | 0.310 |
Why?
| | Gastroschisis | 2 | 2020 | 32 | 0.300 |
Why?
| | Caspase 3 | 1 | 2010 | 238 | 0.300 |
Why?
| | Hemodynamics | 8 | 2009 | 1121 | 0.300 |
Why?
| | Pregnancy Reduction, Multifetal | 2 | 2021 | 5 | 0.300 |
Why?
| | Adult | 31 | 2026 | 40506 | 0.300 |
Why?
| | Lung | 13 | 2024 | 4109 | 0.290 |
Why?
| | Fetal Blood | 4 | 2024 | 342 | 0.290 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2011 | 437 | 0.290 |
Why?
| | Amino Acids, Essential | 1 | 2008 | 13 | 0.290 |
Why?
| | Polycythemia | 2 | 2021 | 25 | 0.290 |
Why?
| | Prospective Studies | 10 | 2025 | 7997 | 0.290 |
Why?
| | Twins, Monozygotic | 2 | 2021 | 134 | 0.280 |
Why?
| | Heart Rate | 2 | 2012 | 855 | 0.270 |
Why?
| | Iliac Vein | 1 | 2008 | 15 | 0.270 |
Why?
| | Animals | 41 | 2021 | 38109 | 0.270 |
Why?
| | Papio | 5 | 2021 | 85 | 0.270 |
Why?
| | Nutritional Status | 1 | 2010 | 354 | 0.270 |
Why?
| | Femoral Vein | 1 | 2008 | 38 | 0.270 |
Why?
| | Iliac Artery | 1 | 2008 | 55 | 0.270 |
Why?
| | Protein Kinases | 1 | 2009 | 315 | 0.260 |
Why?
| | Dystocia | 1 | 2007 | 12 | 0.260 |
Why?
| | Heart Rate, Fetal | 3 | 2026 | 31 | 0.260 |
Why?
| | Pregnancy Trimester, Third | 5 | 2024 | 115 | 0.250 |
Why?
| | MicroRNAs | 2 | 2024 | 701 | 0.240 |
Why?
| | Polyhydramnios | 2 | 2023 | 17 | 0.240 |
Why?
| | Risk Factors | 9 | 2025 | 10792 | 0.230 |
Why?
| | Airway Obstruction | 2 | 2020 | 162 | 0.230 |
Why?
| | Venous Thrombosis | 1 | 2008 | 195 | 0.230 |
Why?
| | Transcription Factors | 2 | 2014 | 1742 | 0.230 |
Why?
| | Retroviridae | 2 | 2002 | 101 | 0.220 |
Why?
| | Umbilical Cord | 6 | 2026 | 91 | 0.220 |
Why?
| | Trophoblasts | 5 | 2015 | 216 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 6 | 2025 | 3869 | 0.210 |
Why?
| | Bartter Syndrome | 1 | 2023 | 7 | 0.210 |
Why?
| | Fellowships and Scholarships | 2 | 2018 | 357 | 0.200 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 338 | 0.200 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2004 | 83 | 0.200 |
Why?
| | Asphyxia | 1 | 2003 | 23 | 0.200 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 21 | 0.200 |
Why?
| | Prenatal Care | 4 | 2022 | 307 | 0.200 |
Why?
| | RNA, Messenger | 7 | 2012 | 2832 | 0.200 |
Why?
| | Fever | 6 | 2009 | 312 | 0.200 |
Why?
| | Pregnancy Proteins | 2 | 2015 | 35 | 0.190 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2024 | 120 | 0.190 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 115 | 0.190 |
Why?
| | Models, Animal | 3 | 2012 | 392 | 0.190 |
Why?
| | Osmolar Concentration | 3 | 2014 | 167 | 0.190 |
Why?
| | Transduction, Genetic | 2 | 2002 | 133 | 0.190 |
Why?
| | Pulmonary Surfactants | 2 | 1993 | 102 | 0.180 |
Why?
| | Blood Vessels | 2 | 2000 | 171 | 0.180 |
Why?
| | Uterine Cervical Diseases | 1 | 2022 | 6 | 0.180 |
Why?
| | Fetal Monitoring | 1 | 2002 | 20 | 0.180 |
Why?
| | Blood Circulation | 1 | 2002 | 44 | 0.180 |
Why?
| | Cesarean Section | 4 | 2026 | 224 | 0.180 |
Why?
| | Meconium | 1 | 2001 | 7 | 0.180 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2001 | 10 | 0.180 |
Why?
| | Cervix Uteri | 1 | 2022 | 50 | 0.180 |
Why?
| | Genetic Vectors | 2 | 2002 | 337 | 0.180 |
Why?
| | Diet, Protein-Restricted | 1 | 2021 | 11 | 0.170 |
Why?
| | Aspirin | 2 | 2015 | 400 | 0.170 |
Why?
| | Rheology | 1 | 2022 | 94 | 0.170 |
Why?
| | Hot Temperature | 3 | 2014 | 407 | 0.170 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2025 | 383 | 0.170 |
Why?
| | Amino Acid Transport System L | 1 | 2021 | 19 | 0.170 |
Why?
| | Case-Control Studies | 6 | 2024 | 3608 | 0.170 |
Why?
| | Emergencies | 1 | 2022 | 176 | 0.170 |
Why?
| | Embryonic and Fetal Development | 5 | 2002 | 93 | 0.170 |
Why?
| | Nasopharynx | 1 | 2001 | 73 | 0.170 |
Why?
| | Amino Acid Transport System A | 1 | 2021 | 37 | 0.170 |
Why?
| | Retrognathia | 1 | 2020 | 4 | 0.170 |
Why?
| | Infant | 8 | 2023 | 10039 | 0.170 |
Why?
| | Twins, Dizygotic | 1 | 2021 | 109 | 0.170 |
Why?
| | Biomarkers | 4 | 2024 | 4275 | 0.160 |
Why?
| | Fetal Death | 3 | 2023 | 58 | 0.160 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 239 | 0.160 |
Why?
| | Sensitivity and Specificity | 6 | 2015 | 1990 | 0.160 |
Why?
| | Heart Diseases | 1 | 2004 | 350 | 0.160 |
Why?
| | Bupivacaine | 1 | 2020 | 38 | 0.160 |
Why?
| | Arm | 2 | 2016 | 110 | 0.160 |
Why?
| | Micrognathism | 1 | 2020 | 19 | 0.160 |
Why?
| | Respiration | 4 | 2006 | 207 | 0.160 |
Why?
| | Myometrium | 2 | 2011 | 38 | 0.160 |
Why?
| | Ductus Arteriosus | 3 | 2018 | 72 | 0.160 |
Why?
| | Anesthetics, Local | 1 | 2020 | 100 | 0.160 |
Why?
| | Goats | 1 | 1999 | 25 | 0.150 |
Why?
| | Respiratory Distress Syndrome, Newborn | 3 | 1999 | 106 | 0.150 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 965 | 0.150 |
Why?
| | Anemia | 1 | 2021 | 188 | 0.150 |
Why?
| | Obstetric Surgical Procedures | 1 | 2019 | 6 | 0.150 |
Why?
| | Leg | 2 | 2016 | 239 | 0.150 |
Why?
| | Reference Values | 4 | 2008 | 798 | 0.150 |
Why?
| | Pregnancy Trimester, Second | 3 | 2017 | 82 | 0.150 |
Why?
| | Immunohistochemistry | 4 | 2010 | 1718 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 52 | 0.140 |
Why?
| | Tocolytic Agents | 1 | 2018 | 16 | 0.140 |
Why?
| | Indomethacin | 1 | 2018 | 76 | 0.140 |
Why?
| | Registries | 2 | 2025 | 2385 | 0.140 |
Why?
| | Time Factors | 8 | 2019 | 7183 | 0.140 |
Why?
| | Colorado | 7 | 2020 | 4564 | 0.140 |
Why?
| | Biological Transport | 3 | 2021 | 418 | 0.130 |
Why?
| | Hyaline Membrane Disease | 2 | 1997 | 20 | 0.130 |
Why?
| | Hysterotomy | 1 | 2017 | 9 | 0.130 |
Why?
| | Maternal Exposure | 1 | 2020 | 213 | 0.130 |
Why?
| | Cardiomyopathies | 1 | 2021 | 338 | 0.130 |
Why?
| | Duodenal Obstruction | 1 | 2017 | 6 | 0.130 |
Why?
| | Antibiotic Prophylaxis | 2 | 2011 | 129 | 0.130 |
Why?
| | Esophageal Atresia | 1 | 2017 | 30 | 0.120 |
Why?
| | Paralysis | 1 | 1997 | 67 | 0.120 |
Why?
| | Attitude | 1 | 2018 | 261 | 0.120 |
Why?
| | Body Mass Index | 3 | 2019 | 2438 | 0.120 |
Why?
| | Caspases | 1 | 2017 | 232 | 0.120 |
Why?
| | Intracranial Embolism and Thrombosis | 1 | 1995 | 7 | 0.120 |
Why?
| | Protein S Deficiency | 1 | 1995 | 8 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 914 | 0.120 |
Why?
| | Placental Circulation | 3 | 2012 | 70 | 0.120 |
Why?
| | Lateral Ventricles | 1 | 2016 | 32 | 0.120 |
Why?
| | Aldehyde Reductase | 2 | 2014 | 31 | 0.120 |
Why?
| | Hypertension | 1 | 2005 | 1264 | 0.120 |
Why?
| | Blotting, Western | 4 | 2011 | 1187 | 0.120 |
Why?
| | Symporters | 2 | 2014 | 48 | 0.110 |
Why?
| | Mannose | 2 | 2012 | 23 | 0.110 |
Why?
| | Curriculum | 1 | 2022 | 1060 | 0.110 |
Why?
| | Hypertension, Pulmonary | 3 | 2022 | 1980 | 0.110 |
Why?
| | Choriocarcinoma | 1 | 2014 | 9 | 0.110 |
Why?
| | Coronary Circulation | 1 | 2015 | 136 | 0.110 |
Why?
| | Fetal Heart | 1 | 2015 | 57 | 0.110 |
Why?
| | Saline Solution, Hypertonic | 1 | 2014 | 42 | 0.110 |
Why?
| | Metformin | 1 | 2018 | 319 | 0.110 |
Why?
| | Regression Analysis | 3 | 2008 | 1003 | 0.110 |
Why?
| | Calcium | 2 | 2011 | 1184 | 0.110 |
Why?
| | Sheep Diseases | 1 | 2014 | 9 | 0.100 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2014 | 13 | 0.100 |
Why?
| | Cohort Studies | 4 | 2020 | 5965 | 0.100 |
Why?
| | Down-Regulation | 3 | 2021 | 627 | 0.100 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 8 | 0.100 |
Why?
| | Caloric Restriction | 1 | 2015 | 127 | 0.100 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 321 | 0.100 |
Why?
| | Uterine Neoplasms | 1 | 2014 | 97 | 0.100 |
Why?
| | Body Weights and Measures | 1 | 2013 | 37 | 0.100 |
Why?
| | Ultrasonography | 2 | 2022 | 770 | 0.100 |
Why?
| | Coronary Vessels | 1 | 2015 | 251 | 0.100 |
Why?
| | Pilot Projects | 3 | 2020 | 1890 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2010 | 906 | 0.100 |
Why?
| | Young Adult | 6 | 2021 | 14126 | 0.100 |
Why?
| | Umbilicus | 1 | 2013 | 17 | 0.100 |
Why?
| | Rabbits | 3 | 2003 | 648 | 0.100 |
Why?
| | Fatty Alcohols | 1 | 1992 | 5 | 0.090 |
Why?
| | Phosphorylcholine | 1 | 1992 | 19 | 0.090 |
Why?
| | Femur | 3 | 2008 | 250 | 0.090 |
Why?
| | Amnion | 1 | 1992 | 28 | 0.090 |
Why?
| | Lung Volume Measurements | 2 | 2023 | 46 | 0.090 |
Why?
| | Longitudinal Studies | 3 | 2013 | 2947 | 0.090 |
Why?
| | NADP | 1 | 2012 | 55 | 0.090 |
Why?
| | Calcium Signaling | 2 | 2011 | 252 | 0.090 |
Why?
| | Signal Transduction | 4 | 2011 | 5233 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1143 | 0.090 |
Why?
| | Isotope Labeling | 1 | 2012 | 83 | 0.090 |
Why?
| | Estradiol | 3 | 2000 | 533 | 0.090 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1563 | 0.090 |
Why?
| | Animals, Newborn | 5 | 2000 | 902 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2001 | 1796 | 0.080 |
Why?
| | Blood Volume | 1 | 2011 | 65 | 0.080 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2010 | 14 | 0.080 |
Why?
| | Pregnancy Trimesters | 1 | 2010 | 20 | 0.080 |
Why?
| | Keratin-18 | 1 | 2010 | 12 | 0.080 |
Why?
| | Galectins | 1 | 2010 | 27 | 0.080 |
Why?
| | Probability | 2 | 2001 | 312 | 0.080 |
Why?
| | Chorionic Villi | 1 | 2010 | 25 | 0.080 |
Why?
| | Abdomen | 2 | 2003 | 141 | 0.080 |
Why?
| | Calcium Channels | 1 | 2011 | 154 | 0.080 |
Why?
| | Carbohydrate Metabolism | 1 | 2010 | 61 | 0.080 |
Why?
| | Carbohydrates | 1 | 2010 | 66 | 0.080 |
Why?
| | Cell Hypoxia | 1 | 2011 | 247 | 0.080 |
Why?
| | Predictive Value of Tests | 4 | 2025 | 2118 | 0.080 |
Why?
| | Term Birth | 1 | 2009 | 25 | 0.080 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2009 | 16 | 0.080 |
Why?
| | TRPC Cation Channels | 1 | 2009 | 14 | 0.080 |
Why?
| | Infant, Premature | 2 | 2012 | 611 | 0.080 |
Why?
| | Diglycerides | 1 | 2009 | 59 | 0.080 |
Why?
| | Oxygen | 4 | 2008 | 995 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1244 | 0.070 |
Why?
| | High-Frequency Ventilation | 2 | 1999 | 45 | 0.070 |
Why?
| | Cordocentesis | 1 | 2008 | 1 | 0.070 |
Why?
| | Middle Cerebral Artery | 1 | 2009 | 56 | 0.070 |
Why?
| | Angiography | 1 | 2009 | 208 | 0.070 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 266 | 0.070 |
Why?
| | Hyperthermia, Induced | 1 | 2010 | 121 | 0.070 |
Why?
| | Crown-Rump Length | 1 | 2008 | 2 | 0.070 |
Why?
| | Endothelin-1 | 2 | 2008 | 184 | 0.070 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1389 | 0.070 |
Why?
| | Placenta Diseases | 1 | 2008 | 19 | 0.070 |
Why?
| | Blood Gas Analysis | 1 | 2008 | 83 | 0.070 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 41 | 0.070 |
Why?
| | Birth Injuries | 1 | 2007 | 18 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 1992 | 655 | 0.060 |
Why?
| | Foot | 1 | 2008 | 100 | 0.060 |
Why?
| | Fluorocarbons | 2 | 1999 | 143 | 0.060 |
Why?
| | Syndrome | 1 | 2008 | 380 | 0.060 |
Why?
| | Pulmonary Circulation | 2 | 2000 | 430 | 0.060 |
Why?
| | Shoulder | 1 | 2007 | 105 | 0.060 |
Why?
| | Body Weight | 3 | 2006 | 978 | 0.060 |
Why?
| | Treatment Outcome | 5 | 2026 | 11695 | 0.060 |
Why?
| | Risk | 1 | 2009 | 911 | 0.060 |
Why?
| | Sheep, Domestic | 1 | 2006 | 33 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 1 | 2006 | 38 | 0.060 |
Why?
| | Polymers | 1 | 2010 | 499 | 0.060 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2009 | 451 | 0.060 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 48 | 0.060 |
Why?
| | Models, Theoretical | 1 | 2009 | 582 | 0.060 |
Why?
| | Fetal Hypoxia | 1 | 2006 | 56 | 0.060 |
Why?
| | Imaging, Three-Dimensional | 1 | 2009 | 583 | 0.060 |
Why?
| | Vasodilation | 2 | 2000 | 523 | 0.060 |
Why?
| | Infant, Premature, Diseases | 1 | 2007 | 111 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 3082 | 0.060 |
Why?
| | Biophysics | 1 | 2006 | 74 | 0.060 |
Why?
| | Epinephrine | 1 | 2026 | 155 | 0.060 |
Why?
| | Echocardiography | 2 | 2021 | 652 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2025 | 2925 | 0.060 |
Why?
| | Receptors, Growth Factor | 2 | 2002 | 56 | 0.060 |
Why?
| | Cerebral Aqueduct | 1 | 2024 | 4 | 0.050 |
Why?
| | Labor, Obstetric | 1 | 2004 | 66 | 0.050 |
Why?
| | Cells, Cultured | 4 | 2014 | 4155 | 0.050 |
Why?
| | Body Size | 1 | 2004 | 95 | 0.050 |
Why?
| | Potassium Chloride | 1 | 2003 | 40 | 0.050 |
Why?
| | Heat-Shock Proteins | 2 | 2014 | 138 | 0.050 |
Why?
| | Self Report | 2 | 2018 | 873 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 557 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 852 | 0.050 |
Why?
| | Fetal Movement | 2 | 2006 | 7 | 0.050 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 109 | 0.050 |
Why?
| | Brain Diseases | 1 | 2004 | 153 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 2 | 2014 | 121 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2004 | 164 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 323 | 0.050 |
Why?
| | beta-Galactosidase | 1 | 2002 | 77 | 0.050 |
Why?
| | Polymerase Chain Reaction | 2 | 2002 | 1054 | 0.050 |
Why?
| | Face | 1 | 2003 | 174 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 272 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 64 | 0.040 |
Why?
| | Apgar Score | 1 | 2001 | 20 | 0.040 |
Why?
| | Lymphokines | 1 | 2002 | 130 | 0.040 |
Why?
| | Bone and Bones | 1 | 2004 | 315 | 0.040 |
Why?
| | Perineum | 1 | 2001 | 37 | 0.040 |
Why?
| | Constriction | 2 | 2018 | 47 | 0.040 |
Why?
| | Cerebral Palsy | 1 | 2004 | 132 | 0.040 |
Why?
| | Light Coagulation | 1 | 2021 | 10 | 0.040 |
Why?
| | Suction | 1 | 2001 | 33 | 0.040 |
Why?
| | Italy | 1 | 2001 | 114 | 0.040 |
Why?
| | Laparoscopy | 2 | 1997 | 475 | 0.040 |
Why?
| | Endpoint Determination | 1 | 2001 | 83 | 0.040 |
Why?
| | Algorithms | 1 | 2009 | 1839 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 377 | 0.040 |
Why?
| | Myocardium | 1 | 2006 | 939 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 428 | 0.040 |
Why?
| | Gene Transfer Techniques | 1 | 2001 | 185 | 0.040 |
Why?
| | Drainage | 1 | 2021 | 185 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2003 | 458 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2003 | 724 | 0.040 |
Why?
| | Airway Management | 1 | 2020 | 79 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 131 | 0.040 |
Why?
| | Maternal Age | 1 | 2020 | 126 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2021 | 521 | 0.040 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2021 | 181 | 0.040 |
Why?
| | Parietal Bone | 1 | 1999 | 9 | 0.040 |
Why?
| | Diffusion | 1 | 1999 | 122 | 0.040 |
Why?
| | Gastrostomy | 1 | 2021 | 130 | 0.040 |
Why?
| | Perinatal Death | 1 | 2019 | 26 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2019 | 44 | 0.040 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1134 | 0.040 |
Why?
| | Arteries | 1 | 2000 | 259 | 0.040 |
Why?
| | Anthropometry | 1 | 1999 | 200 | 0.040 |
Why?
| | Linear Models | 2 | 2017 | 854 | 0.030 |
Why?
| | Cigarette Smoking | 1 | 2020 | 99 | 0.030 |
Why?
| | Insulin | 2 | 2006 | 2507 | 0.030 |
Why?
| | Bronchodilator Agents | 1 | 1999 | 183 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 983 | 0.030 |
Why?
| | Phosphorylation | 2 | 2014 | 1733 | 0.030 |
Why?
| | Male | 6 | 2012 | 72406 | 0.030 |
Why?
| | Pancuronium | 1 | 1997 | 5 | 0.030 |
Why?
| | Tibia | 1 | 1999 | 176 | 0.030 |
Why?
| | Neuromuscular Depolarizing Agents | 1 | 1997 | 6 | 0.030 |
Why?
| | Obstetric Labor, Premature | 1 | 1997 | 39 | 0.030 |
Why?
| | Intestinal Atresia | 1 | 2017 | 17 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 2019 | 216 | 0.030 |
Why?
| | Survival Rate | 1 | 2022 | 2092 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 1998 | 427 | 0.030 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1997 | 62 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2032 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2017 | 5417 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 1997 | 141 | 0.030 |
Why?
| | Pulmonary Edema | 1 | 1997 | 106 | 0.030 |
Why?
| | Respiration, Artificial | 2 | 1999 | 708 | 0.030 |
Why?
| | Administration, Inhalation | 4 | 1999 | 575 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1997 | 134 | 0.030 |
Why?
| | Genetic Counseling | 1 | 2017 | 81 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 144 | 0.030 |
Why?
| | Twins | 1 | 2017 | 156 | 0.030 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 1022 | 0.030 |
Why?
| | Insufflation | 1 | 1995 | 13 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2015 | 69 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 1997 | 294 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2000 | 1311 | 0.030 |
Why?
| | Transport Vesicles | 1 | 2015 | 21 | 0.030 |
Why?
| | Placenta Growth Factor | 1 | 2015 | 26 | 0.030 |
Why?
| | Length of Stay | 1 | 2001 | 1337 | 0.030 |
Why?
| | Saimiri | 1 | 1995 | 9 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2004 | 5872 | 0.030 |
Why?
| | Carbon Dioxide | 2 | 1995 | 242 | 0.030 |
Why?
| | Uterine Prolapse | 1 | 1995 | 14 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1721 | 0.030 |
Why?
| | United States | 3 | 2018 | 15988 | 0.030 |
Why?
| | Aorta | 1 | 1998 | 430 | 0.030 |
Why?
| | Urethral Diseases | 1 | 1995 | 18 | 0.030 |
Why?
| | Neutrophils | 2 | 1999 | 1134 | 0.030 |
Why?
| | Genetic Therapy | 1 | 1997 | 313 | 0.030 |
Why?
| | Sterilization, Tubal | 1 | 1994 | 17 | 0.030 |
Why?
| | Pelvic Inflammatory Disease | 1 | 1994 | 12 | 0.030 |
Why?
| | DNA Fragmentation | 1 | 2014 | 39 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 887 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 836 | 0.020 |
Why?
| | Thoracotomy | 1 | 2013 | 83 | 0.020 |
Why?
| | Program Evaluation | 1 | 2018 | 949 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1540 | 0.020 |
Why?
| | Pregnancy in Diabetics | 1 | 1995 | 121 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1048 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2014 | 200 | 0.020 |
Why?
| | Injections | 1 | 1992 | 197 | 0.020 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 6053 | 0.020 |
Why?
| | Hydrogen | 1 | 2012 | 73 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 144 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2119 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 1993 | 547 | 0.020 |
Why?
| | Drug Combinations | 1 | 1992 | 392 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 845 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 1997 | 676 | 0.020 |
Why?
| | Myo-Inositol-1-Phosphate Synthase | 1 | 2010 | 3 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 138 | 0.020 |
Why?
| | Anticoagulants | 1 | 1995 | 724 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 175 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 2029 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 205 | 0.020 |
Why?
| | TRPC6 Cation Channel | 1 | 2009 | 3 | 0.020 |
Why?
| | Fructose | 1 | 2010 | 130 | 0.020 |
Why?
| | Intracellular Space | 1 | 2009 | 66 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3676 | 0.020 |
Why?
| | Efficiency | 1 | 2009 | 104 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 233 | 0.020 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2008 | 7 | 0.020 |
Why?
| | Sodium | 1 | 2009 | 197 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 2 | 1999 | 119 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 635 | 0.020 |
Why?
| | Head | 1 | 2008 | 120 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2009 | 375 | 0.020 |
Why?
| | Adolescent | 3 | 2017 | 22453 | 0.020 |
Why?
| | Partial Pressure | 1 | 2006 | 31 | 0.020 |
Why?
| | Heating | 1 | 2006 | 18 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 269 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2920 | 0.020 |
Why?
| | Glycogen | 1 | 2006 | 54 | 0.020 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2006 | 55 | 0.020 |
Why?
| | Receptor, Insulin | 1 | 2006 | 94 | 0.010 |
Why?
| | Gene Expression | 1 | 2011 | 1490 | 0.010 |
Why?
| | Forecasting | 1 | 2008 | 391 | 0.010 |
Why?
| | Body Temperature | 1 | 2006 | 229 | 0.010 |
Why?
| | Liver | 2 | 2010 | 1888 | 0.010 |
Why?
| | Lactic Acid | 1 | 2006 | 302 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2011 | 870 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 824 | 0.010 |
Why?
| | Hospitals, University | 1 | 2004 | 176 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 381 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2006 | 346 | 0.010 |
Why?
| | Nuclease Protection Assays | 1 | 2003 | 4 | 0.010 |
Why?
| | Acid-Base Equilibrium | 1 | 2003 | 24 | 0.010 |
Why?
| | Drinking | 1 | 2003 | 44 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2003 | 204 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 85 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 460 | 0.010 |
Why?
| | Respiratory Mechanics | 1 | 2003 | 72 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 74 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2004 | 255 | 0.010 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2002 | 26 | 0.010 |
Why?
| | Placentation | 1 | 2002 | 53 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 80 | 0.010 |
Why?
| | Galactosides | 1 | 2001 | 9 | 0.010 |
Why?
| | Lac Operon | 1 | 2001 | 44 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2609 | 0.010 |
Why?
| | Macaca | 1 | 2001 | 65 | 0.010 |
Why?
| | Microcirculation | 1 | 2002 | 138 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2001 | 156 | 0.010 |
Why?
| | Stomach | 1 | 2001 | 109 | 0.010 |
Why?
| | Morphogenesis | 1 | 2002 | 173 | 0.010 |
Why?
| | Child | 2 | 2020 | 22657 | 0.010 |
Why?
| | Transgenes | 1 | 2001 | 190 | 0.010 |
Why?
| | Glucose | 1 | 2006 | 1049 | 0.010 |
Why?
| | Species Specificity | 1 | 2002 | 574 | 0.010 |
Why?
| | Neovascularization, Physiologic | 1 | 2002 | 194 | 0.010 |
Why?
| | Ligation | 1 | 2000 | 92 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2000 | 68 | 0.010 |
Why?
| | Trachea | 1 | 2001 | 261 | 0.010 |
Why?
| | Hydrocarbons, Brominated | 1 | 1999 | 5 | 0.010 |
Why?
| | Esophagus | 1 | 2001 | 261 | 0.010 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2000 | 150 | 0.010 |
Why?
| | Muscle, Smooth | 1 | 2000 | 153 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1995 | 3890 | 0.010 |
Why?
| | Indoles | 1 | 2001 | 501 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1997 | 63 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1997 | 316 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1997 | 194 | 0.010 |
Why?
| | Blood Glucose | 1 | 2006 | 2330 | 0.010 |
Why?
| | Cell Line | 1 | 2001 | 2882 | 0.010 |
Why?
| | Acidosis, Respiratory | 1 | 1995 | 3 | 0.010 |
Why?
| | Catheterization, Swan-Ganz | 1 | 1995 | 9 | 0.010 |
Why?
| | Central Venous Pressure | 1 | 1995 | 16 | 0.010 |
Why?
| | Postoperative Period | 1 | 1997 | 354 | 0.010 |
Why?
| | Cardiomegaly | 1 | 1997 | 174 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2002 | 1167 | 0.010 |
Why?
| | Prolapse | 1 | 1995 | 6 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1997 | 275 | 0.010 |
Why?
| | Pulmonary Wedge Pressure | 1 | 1995 | 67 | 0.010 |
Why?
| | Vulva | 1 | 1995 | 23 | 0.010 |
Why?
| | Vasodilator Agents | 1 | 1997 | 331 | 0.010 |
Why?
| | Cardiac Output | 1 | 1995 | 179 | 0.010 |
Why?
| | Tidal Volume | 1 | 1995 | 111 | 0.010 |
Why?
| | Lymphocytosis | 1 | 1994 | 11 | 0.010 |
Why?
| | Abdomen, Acute | 1 | 1994 | 21 | 0.010 |
Why?
| | Safety | 1 | 1997 | 356 | 0.010 |
Why?
| | Pressure | 1 | 1995 | 225 | 0.010 |
Why?
| | Anesthesia, General | 1 | 1995 | 118 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1995 | 367 | 0.010 |
Why?
| | General Surgery | 1 | 1997 | 207 | 0.010 |
Why?
| | Catheterization, Peripheral | 1 | 1995 | 119 | 0.010 |
Why?
| | Vagina | 1 | 1995 | 201 | 0.010 |
Why?
| | Oxazoles | 1 | 1971 | 48 | 0.010 |
Why?
| | Penicillins | 1 | 1971 | 61 | 0.010 |
Why?
| | Acute Disease | 1 | 1994 | 1031 | 0.010 |
Why?
| | Chronic Disease | 1 | 1997 | 1813 | 0.010 |
Why?
| | Databases, Factual | 1 | 1997 | 1486 | 0.010 |
Why?
| | Leukocytes | 1 | 1971 | 295 | 0.000 |
Why?
| | Respiratory Tract Infections | 1 | 1971 | 398 | 0.000 |
Why?
| | Mice | 1 | 2001 | 18365 | 0.000 |
Why?
| | Kidney | 1 | 1971 | 1496 | 0.000 |
Why?
| | Middle Aged | 1 | 2006 | 35928 | 0.000 |
Why?
| | Dicloxacillin | 1 | 1971 | 1 | 0.000 |
Why?
| | Evaluation Studies as Topic | 1 | 1971 | 166 | 0.000 |
Why?
| | Imidazoles | 1 | 1971 | 254 | 0.000 |
Why?
| | Administration, Oral | 1 | 1971 | 848 | 0.000 |
Why?
| | Child, Preschool | 1 | 1971 | 11799 | 0.000 |
Why?
|
|
Galan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|